CorWave

Description

CorWave develops an implantable left ventricular assist pump that uses a wave membrane to produce truly pulsatile blood flow for treating patients with advanced heart failure.

CorWave is located in the Paris ecosystem.

Related

• Powerful MedicalPowerful Medical builds PMcardio, an AI ECG platform that detects acute heart attacks and estimates left ventricular function for…
• FineHeartFineHeart develops FlowMaker as a therapy for advanced heart failure, creates clinical-stage cardiology technology, and leads an IPCEI…
• UroMemsUroMems develops smart active implantable medical devices for treating stress urinary incontinence, including the UroActive system for…
• CroíValveCroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in…
• AnaCardioAnaCardio develops novel inotropic drugs that act via the ghrelin signalling pathway to increase cardiomyocyte contractility and cardiac…
• NeuromodNeuromod develops and commercializes Lenire, a bimodal neuromodulation medical device for treating tinnitus, supplying clinicians and…
• Laigo BioLaigo Bio develops SureTACs, bispecific molecules that bind membrane targets and membrane E3 ligases to drive ubiquitin-mediated, lysosomal…
• FIRE1FIRE1 develops NORM, an investigational heart failure management system that combines an implanted sensor in the inferior vena cava with a…
• Enchanted ToolsEnchanted Tools develops the Mirokaï, social robots that combine AI, mobility, and character design to assist people and support teams in…